Squarepoint Ops LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 210 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$22,355
-89.1%
41,146
-2.2%
0.00%
-100.0%
Q3 2022$206,000
+221.9%
42,077
+173.4%
0.00%
Q2 2022$64,000
-54.6%
15,391
-36.6%
0.00%
-100.0%
Q1 2022$141,000
-6.0%
24,272
+93.0%
0.00%0.0%
Q2 2021$150,000
-78.4%
12,573
-77.3%
0.00%
-75.0%
Q1 2021$695,000
-41.0%
55,458
-26.5%
0.00%
-55.6%
Q4 2020$1,178,000
+100.0%
75,478
+21.0%
0.01%
+12.5%
Q3 2020$589,000
+73.7%
62,380
+17.0%
0.01%
-11.1%
Q1 2020$339,000
-61.7%
53,294
-49.7%
0.01%
+80.0%
Q4 2019$886,000
-44.0%
105,869
-39.4%
0.01%
-64.3%
Q3 2019$1,581,000
+138.8%
174,740
+184.1%
0.01%
+133.3%
Q2 2019$662,000
+87.0%
61,508
+65.6%
0.01%
+50.0%
Q1 2019$354,000
+56.6%
37,145
+88.8%
0.00%
+33.3%
Q4 2018$226,000
-62.9%
19,676
-45.3%
0.00%
-57.1%
Q3 2018$609,000
-32.3%
35,950
-43.3%
0.01%
-41.7%
Q2 2018$900,000
-60.7%
63,350
-47.5%
0.01%
-66.7%
Q1 2018$2,291,000
+225.9%
120,561
+181.4%
0.04%
+200.0%
Q4 2017$703,000
+490.8%
42,836
+9.8%
0.01%
+140.0%
Q4 2016$119,000
+33.7%
39,001
+154.9%
0.01%
-16.7%
Q2 2016$89,000
-66.9%
15,300
-48.1%
0.01%
-80.0%
Q4 2015$269,00029,5000.03%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Alexandria Capital, LLC 968,505$12,135,0001.23%
Golden State Equity Partners 126,608$1,586,0000.90%
McGuire Investment Group, LLC 272,801$3,418,0000.72%
Lombard Odier Asset Management (Switzerland) SA 848,429$10,631,0000.70%
Rhenman & Partners Asset Management AB 765,000$9,585,0000.67%
EMC Capital Management 72,061$903,0000.64%
WASATCH ADVISORS LP 10,328,423$129,415,0000.58%
Ceeto Capital Group, LLC 74,000$927,0000.45%
Fort Sheridan Advisors LLC 75,945$952,0000.38%
Vanguard Capital Wealth Advisors 34,580$388,679,0000.33%
View complete list of SANGAMO THERAPEUTICS INC shareholders